Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.
Sulfonylurea is an anti-diabetic drugs widely used in the management of diabetes mellitus type 2. They act by increasing insulin release from the beta cells in the pancreas, by inhibiting the KATP channel
First-generation drugs include acetohexamide, carbutamide, chlorpropamide, glycyclamide (tolhexamide), metahexamide, tolazamide and tolbutamide.
Second-generation drugs include glibenclamide (glyburide), glibornuride, gliclazide, glipizide, gliquidone, glisoxepide and glyclopyramide.
Third-generation drugs include glimepiride, although it is sometimes considered a second-generation agent.
Journal of Obesity and Diabetes emphasize in publishing the original scholarly articles related to Obesity and Diabetes worldwide. The journal follows rapid review process with the Eminent Editorial Board
Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Sulfonylurea, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.
Pharmacists can be part of the healthcare team to help people with diabetes and prediabetes to better health. Obesity and type 2 diabetes are a worldwide epidemic and a problem that can be...
Background: Obesity and Type 2 Diabetes (T2D) are crucial problems worldwide. Oral semaglutide (Rybelsus) was introduced to medical practice for Glucagon-Like Peptide 1 Receptor Agonist...
